rs7045953

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138554.5(TLR4):​c.*8869A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 152,030 control chromosomes in the GnomAD database, including 3,165 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3165 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

TLR4
NM_138554.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0930
Variant links:
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.304 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TLR4NM_138554.5 linkuse as main transcriptc.*8869A>G 3_prime_UTR_variant 3/3 ENST00000355622.8
TLR4NM_003266.4 linkuse as main transcriptc.*8869A>G 3_prime_UTR_variant 4/4
TLR4NM_138557.3 linkuse as main transcriptc.*8869A>G 3_prime_UTR_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TLR4ENST00000355622.8 linkuse as main transcriptc.*8869A>G 3_prime_UTR_variant 3/31 NM_138554.5 P1O00206-1

Frequencies

GnomAD3 genomes
AF:
0.190
AC:
28790
AN:
151912
Hom.:
3155
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.309
Gnomad AMI
AF:
0.0987
Gnomad AMR
AF:
0.142
Gnomad ASJ
AF:
0.230
Gnomad EAS
AF:
0.106
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.0898
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.154
Gnomad OTH
AF:
0.170
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
GnomAD4 genome
AF:
0.190
AC:
28836
AN:
152030
Hom.:
3165
Cov.:
32
AF XY:
0.184
AC XY:
13667
AN XY:
74324
show subpopulations
Gnomad4 AFR
AF:
0.309
Gnomad4 AMR
AF:
0.142
Gnomad4 ASJ
AF:
0.230
Gnomad4 EAS
AF:
0.107
Gnomad4 SAS
AF:
0.121
Gnomad4 FIN
AF:
0.0898
Gnomad4 NFE
AF:
0.154
Gnomad4 OTH
AF:
0.174
Alfa
AF:
0.161
Hom.:
2965
Bravo
AF:
0.198
Asia WGS
AF:
0.141
AC:
492
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.72
DANN
Benign
0.24

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7045953; hg19: chr9-120485795; API